Researchers say levels of microRNA in the blood may be a reliable new biomarker for diagnosing mild cognitive impairment and other forms of dementia.
A new AI algorithm can predict the onset of Alzheimer's disease with an accuracy of over 99% by analyzing fMRI brain scans.
People diagnosed with Alzheimer's or mild cognitive impairment had weaker gamma wave activation in their brains than their peers without the neurodegenerative disorders.
A new algorithm that combines naturalistic driving data with machine learning is 88% accurate at predicting mild cognitive impairment and dementia in older adults.
A new computerized assessment appears to be effective in screening for mild cognitive impairment and dementia within five minutes.
Specific patterns of frontal brainwaves during everyday memory tasks help researchers to predict a patient's risk for developing mild cognitive impairment within five years.
Anticholinergic medications, commonly used for conditions including allergies, high blood pressure, Parkinson's disease, and motion sickness, have been linked to an increased risk of cognitive decline and memory problems, especially in those with genetic risk factors for Alzheimer's disease.
Following the Mediterranean ketogenic diet can help modulate unique fungi found in the gut of those with mild cognitive impairment.
Study reports success in treating cognitive decline and memory loss associated with Alzheimer's disease with the aid of personalized precision medicine.
22% of study participants with severe gum disease developed dementia, and 23% diagnosed with mild cognitive impairment suffered extreme tooth loss. Only 14% of those with healthy gums were later diagnosed with the neurodegenerative disorder. The findings add further evidence for the link between dental hygiene and dementia.
Certain personality traits could increase the risk of developing mild cognitive impairment, a new study reports. Openness was associated with a 6% reduced risk of developing a pre-dementia condition, while those who scored higher for neuroticism had a 6% increased risk of MCI.
Contrary to popular belief, taking a low-dose of aspirin daily does not reduce the risk of developing mild cognitive impairment (MCI). Researchers found no difference between older people who took aspirin and those who took a placebo in the risk of developing MCI, dementia, or Alzheimer's disease.
